Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
